H. Dong

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital · ORCID：0000-0002-1783-711X

发表论文 212 篇 · 总被引 7730 次 · h-index 44

代表论文

• A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia (2024 · New England Journal of Medicine · 被引 48)
• Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial (2024 · Signal Transduction and Targeted Therapy · 被引 33)
• Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial (2025 · BMJ · 被引 6)
• Artificial intelligence-based quantitative bone marrow pathology analysis for myeloproliferative neoplasms (2025 · Haematologica · 被引 6)
• The interaction effects between depression and sleep status on asthma: a national cross-sectional study (2024 · Frontiers in Psychiatry · 被引 5)
• Childhood and adolescent essential thrombocythemia and prefibrotic primary myelofibrosis: insights into diagnosis, outcomes, and treatment from a large Chinese cohort (2024 · Leukemia · 被引 4)